Filing Flows › Cerenome (CNSY) › Q1 2026 › vs Q4 2025
Cerenome (CNSY) Q1 2026 vs Q4 2025 (quarter over quarter)
Cerenome's revenue fell $339K (-25%) from $1.4M in Q4 2025 to $1.0M in Q1 2026.
Cerenome, Q1 2026: revenue $1.0M (-3% year over year), operating margin -692.5%, net loss $6.9M, operating cash flow −$6.2M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $1.0M | $1.4M | −$339K | -25% |
| Other income, net | $173K | $29K | $144K | +497% |
| Net loss | $6.9M | $5.7M | $1.2M | +22% |
| Costs & expenses | $8.1M | $7.1M | $1.0M | +15% |
| Operating costs | $8.1M | $7.1M | $1.0M | +15% |
| Research & development | $2.9M | $2.9M | −$76K | -3% |
| General & admin | $5.3M | $4.2M | $1.1M | +27% |
| Operating cash sources | $7.4M | $7.1M | $241K | +3% |
| Depreciation & amortization | $96K | $145K | −$49K | -34% |
| Share-based compensation | $1.0M | $713K | $309K | +43% |
| Cash used in operations | $6.2M | $6.3M | −$19K | -0.3% |
| Net loss absorbed | $6.9M | $5.7M | $1.2M | +22% |
| Working capital & other | $410K | $1.4M | −$992K | -71% |
Questions
How much did Cerenome's revenue grow quarter over quarter in Q1 2026?
Cerenome's revenue fell $339K (-25%) from $1.4M in Q4 2025 to $1.0M in Q1 2026.